BioSpace News Archive

Icon Group, Australia’s largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase order to further improve the quality of cancer care treatment across its international network.

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2019.

Infinity Pharmaceuticals, Inc. announced its third quarter 2019 financial results and provided an update on the company, including its progress with IPI-549, a first-in-class oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective phosphoinositide-3-kinase-gamma inhibition..

This program offers a unique opportunity for fellows and residents to share notable retina research with peers and mentors.

Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that Fred Colen, CEO of Neovasc, will be participating in the 28th annual Credit Suisse Healthcare Conference in Scottsdale, AZ.

A large study analyzing 107,000 knee replacement surgeries found that African Americans were significantly more likely than white patients to be discharged to an inpatient rehabilitation or skilled nursing facility rather than home care after the procedure.

Vizient, Inc. will host a congressional briefing titled, “Quantifying Quality: Data-Driven Hospital Performance Improvement,” with a panel that includes experts from the University of Kentucky Healthcare and Penn Medicine. U.S. Congressman Brett Guthrie, is also expected to offer remarks at the briefing, which will be held at 12:30 p.m. ET in the Longworth House Office Building in Washington, D.C.

Water fluoridation is linked to Attention-Deficit/Hyperactivity Disorder (ADHD) (Environment International December 2019), adding to the growing pile of scientific literature linking fluoride to neurological disorders e.g. lower IQ, Autism, poor memory, dementia, Alzheimer’s Disease.

The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States House of Representatives.

With a shared commitment to innovation, the alliance aims to support a healthier humanity--starting with healthier guests